Introduction
Bilateral orchidectomy has been a standard form of treatment for advanced prostatic cancer since Huggins and his colleagues in 1941 showed that many patients with the disease experienced clinical improvement, with osteosclerosis of metastases three to six months after castration. Huggins et al. noted that the presence of testes markedly lighter than the normal weight was a bad prognostic sign and that the clinical course following orchidectomy could also be related to the cellular pattern of the primary tumour, being unfavourable when the tumour was undifferentiated (Huggins, 1942; Huggins, Stevens and Hodges, 1941) .
The efficacy of castration has been ascribed to a reduction in testicular hormones and measurement of plasma testosterone levels before and after both total and subcapsular orchidectomy has confirmed that considerable reduction of testosterone levels occurs (Robinson and Thomas, 1971; Shearer et al., 1973; Burge et al., 1976) . These and other observations have led to the view that carcinoma of the prostate is an androgen-dependent tumour, despite the paradox that the condition occurs predominantly in men past the fifth decade at a time when testicular function is often declining (Leading Article, 1975) . Moreover no significant differences in the levels of plasma testosterone between men with carcinoma of the prostate and age-matched controls have been reported, although the levels may be lower in men with metastatic carcinoma of the prostate (Robinson and Thomas, 1971 
Patients and methods
The study was performed on twenty patients suffering from advanced prostatic cancer -Veterans Stage 3 and 4 (VACURG, 1967 Cancer (1974) .
Hormone measurements
Blood samples were obtained before operation and six months later. The plasma was separated and stored at -20°C until assayed. The pre-and postoperative samples of every patient were measured in the same assay. Plasma testosterone was determined by radio-immuno assay (RIA) in the Division of Steroid Endocrinology, University of Leeds, using a testosterone antiserum raised in a rabbit against testosterone -3 -(O -carboxymethyl) -oxime -bovine serum albumin conjugate prepared according to the method described by Habib et al. (1976) . The normal range in men aged 18 60 years is 8-27 nmol/l.
Since circulating dihydrotestosterone (DHT) levels are about one-tenth those of testosterone in adult 0032-5473/78/0400-0261 $02.00 (e 1978 The Fellowship of Postgraduate Medicine men aged 20-39 years, rising to about one-fifth in men aged 60-90 years (Horton et al., 1975) , and the cross reactivity with DHT of the antiserum used was 52%Y, no correction was applied for any DHT present. Plasma LH and FSH were measured in specific RIA, using the method described by Jacobs and Lawton (1974) 02 -2-0 ng/ml LH and 16 -50 ng/ml FSH Treatment Apart from bilateral orchidectomy (total or subcapsular), the only additional treatments were transurethral resection of the prostate and analgesics.
Assessment
Clinical assessment was made at six months. The most important subjective parameters used were improvement in performance status and reduction in pain. The most important indications of objective remissions used were diminution of the number or size of metastases, or a 50%. reduction in the size of the primary tumour, followed by reduction in the serum acid phosphatase, rise in haemoglobin and weight gain. The overall responses were graded as follows:
(1) Very good -subjective and objective remission.
(2) Good -subjective remission. (3) No change. (4) Poor -progression of disease.
Results Table 1 shows the age, stage, histological grade, type of orchidectomy, pre-orchidectomy concentrations of FSH, LH and testosterone and response to treatment. Fig. 1 shows the pre-and the 6-month post-orchidectomy concentrations of FSH, LH and testosterone. Fig. 2 shows the pre-treatment levels of FSH, LH and testosterone in relation to response. Clinical improvement was seen in 50% of the patients at 6 months.
Discussion
There were no significant differences with respect to age, clinical stage, type of operation or pretreatment levels of FSH, LH and testosterone between the groups of patients that were improved or not improved after castration. There was no significant difference between the fall of plasma testosterone with respect to the type of operation performed. Pre-operatively two of the patients had 'compensated' Leydig cell failure, as indicated by (Bramble et al., 1975) . Both these patients also had high levels of FSH. It is not unexpected for patients in this age group to have elevated levels of LH and FSH (Baier, Biro and Weinges, 1974; Steams et al., 1974) but it is clear that it is of no prognostic importance with respect to treatment by orchidectomy. These measurements are analagous to Huggins' measurement of testicular weight and it is interesting to note that the three patients of Huggins (1942) who had small testes also had tumours that were undifferentiated. It is perhaps this latter factor that was more important from the prognostic point of view, particularly as in the present series seven of the ten patients showing improvement had well differentiated tumours, while only one of the ten who did not improve had a well differentiated tumour (Table  2) . This difference was statistically significant (Fisher's Exact Test P = 0 05). These data therefore confirm Huggins' original (1942) observations on the prognostic importance of the histological grade of the primary tumour and suggest that pre-operative Leydig cell function should not be used to determine the need for endocrine therapy.
